covid
Buscar en
Endocrinología y Nutrición
Toda la web
Inicio Endocrinología y Nutrición Control del peso corporal. Perspectivas actuales
Información de la revista
Vol. 51. Núm. 7.
Páginas 397-400 (agosto 2004)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 51. Núm. 7.
Páginas 397-400 (agosto 2004)
Acceso a texto completo
Control del peso corporal. Perspectivas actuales
Visitas
3589
J. Gómez-ambrosi
Autor para correspondencia
jagomez@unav.es

Correspondencia: Dr. J. Gómez-Ambrosi. Laboratorio de Investigación Metabólica. Edificio CIFA. Clínica Universitaria de Navarra. Universidad de Navarra. Irunlarrea, 1. 31008 Pamplona. España
Laboratorio de Investigación Metabólica. Clínica Universitaria de Navarra. Universidad de Navarra. Pamplona. España
Este artículo ha recibido
Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
G. Fruhbeck, J. Gomez-Ambrosi.
Control of body weight: a physiologic and transgenic perspective.
Diabetologia, 46 (2003), pp. 143-172
[2.]
B.M. Spiegelman, J.S. Flier.
Obesity and the regulation of energy balance.
Cell, 104 (2001), pp. 531-543
[3.]
J.O. Hill, H.R. Wyatt, G.W. Reed, J.C. Peters.
Obesity and the environment: where do we go from here?.
Science, 299 (2003), pp. 853-855
[4.]
S. Kenchaiah, J.C. Evans, D. Levy, P.W. Wilson, E.J. Benjamin, M.G. Larson, et al.
Obesity and the risk of heart failure.
N Engl J Med, 347 (2002), pp. 305-313
[5.]
K.R. Fontaine, D.T. Redden, C. Wang, A.O. Westfall, D.B. Allison.
Years of life lost due to obesity.
JAMA, 289 (2003), pp. 187-193
[6.]
E.E. Calle, C. Rodriguez, K. Walker-Thurmond, M.J. Thun.
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults.
N Engl J Med, 348 (2003), pp. 1625-1638
[7.]
A. Cheng, N. Uetani, P.D. Simoncic, V.P. Chaubey, A. Lee-Loy, C.J. McGlade, et al.
Attenuation of leptin action and regulation of obesity by protein tyrosine phosphatase 1B.
Dev Cell, 2 (2002), pp. 497-503
[8.]
G. Fruhbeck, J. Gomez Ambrosi.
Rationale for the existence of additional adipostatic hormones.
FASEB J, 15 (2001), pp. 1996-2006
[9.]
G. Fruhbeck, J. Gomez-Ambrosi, F.J. Muruzabal, M.A. Burrell.
The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation.
Am J Physiol Endocrinol Metab, 280 (2001), pp. E827-E847
[10.]
V. Wallenius, K. Wallenius, B. Ahren, M. Rudling, H. Carlsten, S.L. Dickson, et al.
Interleukin-6-deficient mice develop matureonset obesity.
Nat Med, 8 (2002), pp. 75-79
[11.]
F. Massiera, M. Bloch-Faure, D. Ceiler, K. Murakami, A. Fukamizu, J.M. Gasc, et al.
Adipose angiotensinogen is involved in adipose tissue growth and blood pressure regulation.
FASEB J, 15 (2001), pp. 2727-2729
[12.]
A. Fortuno, A. Rodriguez, J. Gomez-Ambrosi, P. Muniz, J. Salvador, J. Diez, et al.
Leptin inhibits angiotensin II-induced intracellular calcium increase and vasoconstriction in the rat aorta.
Endocrinology, 143 (2002), pp. 3555-3560
[13.]
S. Engeli, P. Schling, K. Gorzelniak, M. Boschmann, J. Janke, G. Ailhaud, et al.
The adipose-tissue renin-angiotensin-aldosterone system: role in the metabolic syndrome?.
Int J Biochem Cell Biol, 35 (2003), pp. 807-825
[14.]
P.E. Morange, D. Bastelica, M.F. Bonzi, B. Van Hoef, D. Collen, I. Juhan-Vague, et al.
Influence of t-PA and u-PA on adipose tissue development in a murine model of diet-induced obesity.
Thromb Haemost, 87 (2002), pp. 306-310
[15.]
D.E. Cummings, D.S. Weigle, R.S. Frayo, P.A. Breen, M.K. Ma, E.P. Dellinger, et al.
Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery.
N Engl J Med, 346 (2002), pp. 1623-1630
[16.]
M.A. Cowley, R.G. Smith, S. Diano, M. Tschop, N. Pronchuk, K.L. Grove, et al.
The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis.
Neuron, 37 (2003), pp. 649-661
[17.]
R.L. Batterham, M.A. Cowley, C.J. Small, H. Herzog, M.A. Cohen, C.L. Dakin, et al.
Gut hormone PYY3-36 physiologically inhibits food intake.
Nature, 418 (2002), pp. 650-654
[18.]
K. Miyawaki, Y. Yamada, N. Ban, Y. Ihara, K. Tsukiyama, H. Zhou, et al.
Inhibition of gastric inhibitory polypeptide signaling prevents obesity.
Nat Med, 8 (2002), pp. 738-742
[19.]
A. Asakawa, A. Inui, H. Yuzuriha, N. Ueno, G. Katsuura, M. Fujimiya, et al.
Characterization of the effects of pancreatic polypeptide in the regulation of energy balance.
Gastroenterology, 124 (2003), pp. 1325-1336
[20.]
J. Berger, D.E. Moller.
The mechanisms of action of PPARs.
[21.]
Y.X. Wang, C.H. Lee, S. Tiep, R.T. Yu, J. Ham, H. Kang, et al.
Peroxisome-proliferator-activated receptor δ activates fat metabolism to prevent obesity.
Cell, 113 (2003), pp. 159-170
[22.]
A. Cederberg, L.M. Gronning, B. Ahren, K. Tasken, P. Carlsson, S. Enerback.
FOXC2 is a winged helix gene that counteracts obesity, hypertriglyceridemia, and diet-induced insulin resistance.
Cell, 106 (2001), pp. 563-573
[23.]
F. Picard, M. Gehin, J. Annicotte, S. Rocchi, M.F. Champy, B.W. OšfMalley, et al.
SRC-1 and TIF2 control energy balance between white and brown adipose tissues.
Cell, 111 (2002), pp. 931-941
[24.]
P. Puigserver, B.M. Spiegelman.
Peroxisome Proliferator-activated receptor-gamma coactivator 1a (PGC-1¿): transcriptional coactivator and metabolic regulator.
Endocr Rev, 24 (2003), pp. 78-90
[25.]
W.T. Garvey.
The role of uncoupling protein 3 in human physiology.
J Clin Invest, 111 (2003), pp. 438-441
[26.]
E. Nisoli, E. Clementi, C. Paolucci, V. Cozzi, C. Tonello, C. Sciorati, et al.
Mitochondrial biogenesis in mammals: the role of endogenous nitric oxide.
Science, 299 (2003), pp. 896-899
[27.]
J. Hirosumi, G. Tuncman, L. Chang, C.Z. Gorgun, K.T. Uysal, K. Maeda, et al.
A central role for JNK in obesity and insulin resistance.
Nature, 420 (2002), pp. 333-336
[28.]
P. Cohen, C. Zhao, X. Cai, J.M. Montez, S.C. Rohani, P. Feinstein, et al.
Selective deletion of leptin receptor in neurons leads to obesity.
J Clin Invest, 108 (2001), pp. 1113-1121
[29.]
T. Kitamura, C.R. Kahn, D. Accili.
Insulin receptor knockout mice.
Annu Rev Physiol, 65 (2003), pp. 313-332
[30.]
N. Yahagi, H. Shimano, A.H. Hasty, T. Matsuzaka, T. Ide, T. Yoshikawa, et al.
Absence of sterol regulatory element-binding protein-1 (SREBP-1) ameliorates fatty livers, but not obesity or insulin resistance in Lepob/Lepob mice.
J Biol Chem, 277 (2002), pp. 19353-19357
[31.]
E.S. Bachman, H. Dhillon, C.Y. Zhang, S. Cinti, A.C. Bianco, B.K. Kobilka, et al.
βAR signaling required for diet-induced thermogenesis and obesity resistance.
Science, 297 (2002), pp. 843-845
[32.]
P. Cohen, M. Miyazaki, N.D. Socci, A. Hagge-Greenberg, W. Liedtke, A.A. Soukas, et al.
Role for stearoyl-CoA desaturase-1 in leptin-mediated weight loss.
Science, 297 (2002), pp. 240-243
[33.]
E.E. Schadt, S.A. Monks, T.A. Drake, A.J. Lusis, N. Che, V. Colinayo, et al.
Genetics of gene expression surveyed in maize, mouse and man.
Nature, 422 (2003), pp. 297-302
[34.]
D.E. Cummings, M.W. Schwartz.
Genetics and pathophysiology of human obesity.
[35.]
I.S. Farooqi, J.M. Keogh, G.S. Yeo, E.J. Lank, T. Cheetham, S. Ošf-Rahilly.
Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene.
N Engl J Med, 348 (2003), pp. 1085-1095
[36.]
J. Korner, L.J. Aronne.
The emerging science of body weight regulation and its impact on obesity treatment.
J Clin Invest, 111 (2003), pp. 565-570
Copyright © 2004. Sociedad Española de Endocrinología y Nutrición
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos